Product description
Hydralyte Strawberry Kiwi Effervescent Electrolyte 20 Tablets
All batches within expiry
Batch Numbers: L9136/1, L9198/7, L9268/5, L9309/1, L0108/11, L0205/4, L0031/7,
L0031/8, L0066/4, and L0311/5
Material Numbers: HLESK20 and HLESK60
AUST L 288102
All batches within expiry
Batch Numbers: L9136/1, L9198/7, L9268/5, L9309/1, L0108/11, L0205/4, L0031/7,
L0031/8, L0066/4, and L0311/5
Material Numbers: HLESK20 and HLESK60
AUST L 288102
See a list of details to help identify the product
Reason the product is recalled
The product contains Carthamus tinctorius flower (safflower flower) extract, as an inactive ingredient, but does not include the required pregnancy warning label.
The hazards to consumers
Medicines containing Carthamus tinctorius (safflower), taken by pregnant women or women who become pregnant, may cause injury to unborn children.
What consumers should do
Consumers should not take the product if they are pregnant, or likely to become pregnant. Consumers should take the affected product to the place of purchase for a full refund.
Anyone who is concerned in any way about the use of this product should consult their doctor.
For more information, consumers can contact Care Pharmaceuticals Customer Service on 1800 788 870.
Anyone who is concerned in any way about the use of this product should consult their doctor.
For more information, consumers can contact Care Pharmaceuticals Customer Service on 1800 788 870.
Details to help identify the product
Supplier running the recall
Who sold the product
Chemist Warehouse
API
Symbion
Sigma
Barrett Distributors
National Pharmacies
CH2
API
Symbion
Sigma
Barrett Distributors
National Pharmacies
CH2
Identifying numbers
Barcode number
9317039001498 , 9317039001726
Dates available for sale
-
Where the product was sold
Nationally
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2021/19035 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.